首页 | 本学科首页   官方微博 | 高级检索  
检索        

对一项多中心Ⅲ期随机对照大剂量化疗应用于侵袭性淋巴瘤初始治疗研究的评论
引用本文:石远凯,李文瑜.对一项多中心Ⅲ期随机对照大剂量化疗应用于侵袭性淋巴瘤初始治疗研究的评论[J].循证医学,2008,8(5):264-266.
作者姓名:石远凯  李文瑜
作者单位:1. 中国医学科学院肿瘤医院内科, 北京,100021;2. 广东省人民医院肿瘤中心, 广州,510080
摘    要:1文献来源 Kaiser U, Uebelacker I, Abel U, et al. Randomized study to evaluated the use of highdose therapy as part of "aggressive" lymphoma J]. 4413-4419. primary treatment for J Clin Oncol, 20 (22) :

关 键 词:侵袭性淋巴瘤  大剂量化疗  初始治疗

Review on Randomized Study to Evaluate the Use of High-Dose Therapy as Part of Primary Treatment for "Aggressive" Lymphoma
SHI Yuan-kai,LI Wen-yu.Review on Randomized Study to Evaluate the Use of High-Dose Therapy as Part of Primary Treatment for "Aggressive" Lymphoma[J].The Journal of Evidence-Based Medicine,2008,8(5):264-266.
Authors:SHI Yuan-kai  LI Wen-yu
Institution:SHI Yuan-kai1,LI Wen-yu2 Department of Medical Oncology,Cancer Hospital,Chinese Academy of Medical Sciences,Beijing 100021,China
Abstract:1 文献来源 Kaiser U,Uebelacker I,Abel U,et al.Randomized study to evaluated the Use of highdose therapy as part of primary treatment for "aggressive"lymphomaJ].J Clin Oneol,20(22):4413-4419.
Keywords:aggressive lymphoma  high-dose therapy  primary treatment  
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《循证医学》浏览原始摘要信息
点击此处可从《循证医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号